INTRACAVERNOUS INJECTION THERAPY FOR MALE ERECTILE DYSFUNCTION

Intracavernosal injection therapy has consistently produced erections in 60% to 70% of patients in whom it is tried. About 70% of patients e nter long-term therapy and there is a dropout rate of 20% to 50% withi n the first year. The most effective current regimen is a mixture of p apaverine-phentolamine and prostaglandin E1, that also seems to have a relatively low incidence of priapism and fibrous nodule formation. Pa tient education is vitally important to the success of a program. Pati ent satisfaction rates are high.